Article Details

FDA Pauses Authorization For Eli Lilly's COVID Antibody Treatment

Retrieved on: 2022-12-01 21:58:04

Tags for this article:

Click the tags to see associated articles and topics

FDA Pauses Authorization For Eli Lilly's COVID Antibody Treatment. View article details on hiswai:

Excerpt

"Lilly will continue to search and evaluate monoclonal antibodies to identify potential candidates for clinical development against new variants.".

Article found on: www.ibtimes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up